Triptans, as selective serotonin 5-HT1B/1D receptor agonists, work by causing vasoconstriction of cranial blood vessels and inhibiting neuropeptide release in trigeminal pathways. When used for Cluster Headache, these medications rapidly reduce neurovascular inflammation and interrupt pain signaling, providing acute relief by targeting the underlying pathophysiological mechanisms of the headache.